UFC 172 Weigh-In Results

mma-teixeira01-360

BALTIMORE, MD (The Spread) – The fighters hit the scales for UFC 172 on Friday, making the main-card bouts official. Here is a look at the weigh-in results.

View Real-Time Sports Betting Odds

UFC 172 will take place from the Baltimore Arena in Baltimore, Maryland with the main card bouts airing live on PPV at 10PM ET.

The main event of Saturday’s card is a bout for the Light Heavyweight Title as Jon Jones (19-1) defends his title against Glover Teixeira (22-2). According to oddsmakers at Bovada.lv, Jones is the favorite to win this fight, as he has odds of -550 to prevail. Teixeira has a money line of +375 to win. Teixeira came in at 205 pounds, as did the champion Jones. Following the scales, the two faced off and then got face-to-face. Jones typically doesn’t look at his opponent, but he did for this fight and looked pretty intense in doing so. Teixeria has the one-punch power to win this fight while Jones has the reach and wrestling to control the fight.

The co-main event of Saturday’s event is also a light heavyweight clash, which features Phil Davis (12-1) taking on Anthony Johnson (16-4). Oddsmakers have Davis favored at home, as he has odds of -230 to win, while Johnson has a money line of +180 to prevail. Johnson, a former welterweight contender, weighed in at 205 pounds on Friday while Davis also came in at 205 pounds. The two had a very tame stare down before shaking hands. This fight will come down to the striking of Johnson vs. the grappling of Davis.

For complete weigh-in results for the bouts that will take place at UFC 172, see below.

UFC 172 Main Card Weigh-In Results

Jon Jones (205) vs. Glover Teixeira (205)

Phil Davis (205.5) vs. Anthony Johnson (205)

Tim Boetsch (185.5) vs. Luke Rockhold (185.5)

Yancy Medeiros (155.5) vs. Jim Miller (155)

Andre Fili (145) vs. Max Holloway (145)

Bet on UFC Odds

Want More From TheSpread.com? Follow us on Twitter and Facebook or Subscribe to Our News Feeds!

Sports Insights' Advanced Betting Tools - NFL Free 14-Day Trial